Article thumbnail

CONSORT recommendations in abstracts of randomised, controlled trials on migraine and headache

By Peer Carsten Tfelt-Hansen

Abstract

A CONSORT statement on the content of abstracts of randomised, controlled trials (RCTs) was published in 2008. I therefore reviewed the abstracts from 2009 to 2010 published on RCTs in Cephalalgia, Headache and other (non-headache) journals. The following items were reviewed: number of patients, reporting of response either in percentages or absolute values, the use of p values, and effect size with its precision. The latter was recommended in the CONSORT statement. A total of 46 abstracts were reviewed and effect size with 95% confidence intervals was only reported in seven abstracts. The influence of the CONSORT statement on reporting in abstracts has so far only had a limited influence on the headache literature

Topics: Review Article
Publisher: Springer Milan
OAI identifier: oai:pubmedcentral.nih.gov:3173641
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2011). 12:505–510 123prevention of difficult-to-treat menstrual migraine attacks.
  2. (2009). A double-blind comparison of onabotulinumtoxinA (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.
  3. (2009). A placebo-controlled surgical trial of migraine headaches. Plast Reconstr Surg 124:461–468
  4. (2010). A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department.
  5. (2009). A randomized, double-blind, placebo-controlled study of MAP0004 in adult patients with migraine.
  6. (2010). A randomized, placebocontrolled trial of acetaminophen for treatment of migraine headache.
  7. (2010). Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan—a randomized proof-ofconcept trial.
  8. Arts W-F et al (2010) Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial.
  9. (2009). CAPSS-277 Investigator Group. Topiramate versus amitriptyline in migraine prevention: a 26-weeks, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
  10. (2009). CeballosBauman A
  11. (2009). Consistency of response to sumatriptan/naproxen sodium in a placebo-controlled, crossover study.
  12. (2008). CONSORT for reporting randomised trials in journal and conference abstracts.
  13. Czech Migraine Investors Group. Intranasal sumatriptan powder delivered by a novel breath-activated bi-directional device for the acute treatment of migraine: a randomized, placebo-controlled study.
  14. (2010). Diet restriction in migraine, based on IgG against food: a clinical double-blind, randomized, crossover, trial.
  15. Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimized acute treatment in frequent migraine: randomized controlled trial.
  16. (2009). Effects of tonabersat on migraine with aura: a randomized, double-blind, placebo-controlled crossover study.
  17. (2009). Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine, a double-blind, parallel-group randomized study.
  18. (2010). Efficacy and tolerability of a new powered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: results from the International Migraine Pain Assessment Clinical Trial (IMPACT).
  19. (2009). Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
  20. Fan X et al (2009) Randomized, controlled trial of telcagepant for the acute treatment of migraine.
  21. (2009). Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
  22. (2010). For the CONSORT Group
  23. Haag A et al (2010) Low-frequency rTMS of the vertex in the prophylactic treatment of migraine.
  24. Klapper JA et al (2009) Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, doseranging studies of acute migraine.
  25. (2010). Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache.
  26. Lipton RB et al (2010) OnabotulinumtoxinA for treatment of chronic migraine. Results from the double-blind, randomized, placebo-controlled phase of
  27. Lipton RB et al (2010) OnabotulinumtoxinA for treatment of chronic migraine. Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.
  28. (2009). Memantine for prophylaxis of chronic tension-type headache. A double-blind, randomized, crossover clinical trial.
  29. (2009). Mills: Tonabersat TON-01–05 Study Group. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression agent tonabersat in migraine prophylaxis.
  30. Omboni S et al (2010) Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, multicenter, randomized, Italian study. Neurol Sci 31(Suppl 1):S115–S119
  31. (2010). OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
  32. OppJ et al (2010) Lack of efficacy of manual therapy in children and adolescents with suspected cervicogenic headache: results of a prospective, randomized, placebo-controlled and blinded trial.
  33. Pearlman SH et al (2010) Single-pulse transcranial magnetic stimulation for acute migraine with aura: a randomized, doubleblind parallel-group sham-controlled trial.
  34. (2010). Prophylactic etoricoxib preventing Yom Kippur headache: a placebo-controlled double-blind and randomized trial of prophylaxis for ritual fasting headache.
  35. (2010). Prophylaxis of migraine with melatonin: a randomised controlled trial.
  36. (2010). Prospective, double-blind, randomized, placebocontrolled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation of Altitude Trial (HEAT).
  37. (2010). Randomized, controlled trial of telcagepant over four migraine attacks.
  38. (2009). Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine J Headache Pain (2011) 12:505–510 509 123prevention in pediatric subjects 12 to 17 years of age.
  39. Rizatriptan 10-mg ODT for early treatment of migraine and impact of migraine education on treatment of response.
  40. (2009). Rosin A
  41. (2010). Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension.
  42. (2009). Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
  43. (2009). Subcutaneous histamine versus botulinum toxin type A in migraine prophylaxis: a randomized, double-blind study.
  44. Sun G et al (2009) Acupuncture for treating acute attacks of migraine: a randomized controlled trial.
  45. (2009). Telmisartan in migraine prophylaxis: a randomized, placebo-controlled trial.
  46. (2009). Topiramate treatment of chronic migraine, a randomized placebo-controlled trial of quality of life and other measures.
  47. (2010). Treating headache recurrence after emergency department discharge: a randomized, controlled trial of naproxen versus sumatriptan. Ann Emerg Med 56:7–17
  48. White JD et al (2009) Combination treatment for menstrual migraine and dysmenorrheal using sumatriptan–naproxen: two randomized controlled trials.
  49. (2009). Zolmitriptan nasal spray in the acute treatment of cluster headache. A meta-analysis of two studies.